Stockscreener 앱 받기
1.7401
1.42%
-0.0199
전일 마감가:
$1.76
열려 있는:
$1.76
하루 거래량:
44,528
Relative Volume:
0.07
시가총액:
$37.72M
수익:
$179.02M
순이익/손실:
$-57.29M
주가수익비율:
-0.6331
EPS:
-2.7487
순현금흐름:
$-33.01M
1주 성능:
-0.86%
1개월 성능:
-12.81%
6개월 성능:
-38.26%
1년 성능:
-44.75%
1일 변동 폭
$1.735
$1.7681
1주일 범위
$1.71
$1.83
52주 변동 폭
$1.57
$4.10
Petmed Express Inc Stock (PETS) Company Profile
명칭
Petmed Express Inc
전화
(561) 426-4444
주소
420 SOUTH CONGRESS AVENUE, DELRAY BEACH
Compare PETS vs HITI, SCNX, POM, MEDS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PETS
Petmed Express Inc
|
1.74 | 38.15M | 179.02M | -57.29M | -33.01M | -2.7487 |
HITI
High Tide Inc
|
2.475 | 215.28M | 486.49M | -33.29M | 10.86M | -0.3627 |
SCNX
Scienture Holdings Inc
|
0.432 | 19.37M | 656.60K | -16.79M | -11.12M | -1.0743 |
POM
Pomdoctor Ltd Adr
|
0.9556 | 7.61M | 0 | 0 | 0 | 0.00 |
MEDS
Trxade Health Inc
|
1.321 | 4.44M | 7.15M | 4.03M | -11.33M | -5.40 |
Petmed Express Inc Stock (PETS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-05-25 | 개시 | Lake Street | Buy |
| 2022-01-20 | 업그레이드 | Sidoti | Neutral → Buy |
| 2021-11-18 | 개시 | Morgan Stanley | Underweight |
| 2021-10-01 | 개시 | Jefferies | Hold |
| 2021-08-05 | 재개 | Credit Suisse | Underperform |
| 2021-06-03 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2021-03-05 | 업그레이드 | Sidoti | Neutral → Buy |
| 2021-01-27 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2020-08-19 | 업그레이드 | Sidoti | Neutral → Buy |
| 2020-04-09 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2020-03-12 | 업그레이드 | Sidoti | Neutral → Buy |
| 2020-02-24 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2019-08-16 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2018-06-15 | 개시 | CL King | Neutral |
| 2017-08-24 | 업그레이드 | Sidoti | Neutral → Buy |
| 2017-07-24 | 업그레이드 | Northcoast | Neutral → Buy |
| 2016-05-09 | 업그레이드 | Craig Hallum | Sell → Hold |
| 2016-02-04 | 개시 | Credit Suisse | Underperform |
| 2010-07-19 | 다운그레이드 | CL King | Strong Buy → Accumulate |
| 2010-07-19 | 재확인 | JMP Securities | Mkt Outperform |
| 2010-05-25 | 다운그레이드 | Wedbush | Neutral → Underperform |
| 2010-05-06 | 재확인 | Wedbush | Neutral |
| 2010-03-23 | 다운그레이드 | Janney Mntgmy Scott | Buy → Neutral |
| 2010-03-18 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2010-02-16 | 재확인 | CL King | Strong Buy |
| 2009-07-21 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2009-01-07 | 개시 | CL King | Strong Buy |
모두보기
Petmed Express Inc 주식(PETS)의 최신 뉴스
PetMeds (PETS) Q1 FY2027 Results Show Stabilizing Revenue but No Margin Relief Yet - AlphaStreet
PetMed Express (PETS) Q1 2027 Earnings Call Transcript - AOL.com
Petwealth and Kennel Connection Accelerate Partnership Following Strong Industry Response at SuperZoo 2026 - AOL.com
PetMed (PETS) Financial Update: EPS Falls Short of Its Estimate at the Close; After Earnings: The Stock Loses 1.67% in Latest TradingShare Repurchase Impact - vinanet.vn
150-year-old Cheltenham pharmacy rescued from administration - AOL.co.uk
Petmed Express Inc (PETS) Stock News Today - TradingKey
Full Transcript: PetMed Express Q1 2027 Earnings Call - Sahm
PetMed Express Q1 Earnings Miss Estimates, Sales Decline Y/Y - Yahoo Finance
PetMed Express Q1 2027 Earnings Call Transcript - MarketBeat
PetMed Express (PETS) Fiscal Q1 2027 Earnings Call: Sales Stabilize Above $40 Million - TradingKey
Israel Business NewsGlobes - Globes - Israel Business News
PetMed Express Inc (PETS) (Q1 2027) Earnings Call Highlights: Na - GuruFocus
PetMed Express earnings missed by $0.40, revenue fell short of estimates - Investing.com Canada
PetMed Express, Inc. Q1 2027 Earnings Call Summary - Yahoo Finance
Is PetMed Express Inc (PETS) a Value Opportunity After Q1 Earnin - GuruFocus
PetMed (PETS) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Earnings call transcript: PetMed Express misses Q1 2027 estimates as shares fall - Investing.com Nigeria
PetMed Express (PETS) grants 60,000 restricted shares to interim CEO Campbell - Stock Titan
PetMed Express Q1 loss narrows 82% to $6.1 million as sales fall 19.9% - scanx.trade
PetMed Express, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
PETMED EXPRESS INC 2026: Revenue $41.02M, EPS ($0.28) — 10-Q Summary - TradingView
PetMed Express, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026 - marketscreener.com
PetMed Express (PETS) Stock Falls on Q1 2027 Earnings - Quiver Quantitative
PetMed: Fiscal Q1 Earnings Snapshot - marketscreener.com
Q1 2027 Petmed Express Inc Earnings Call Transcript - GuruFocus
Renaissance Technologies reports 5.29% PetMed Express (PETS) ownership stake in updated filing - Stock Titan
PetMed Express : PetMeds® Announces First Quarter Financial Results - marketscreener.com
PetMed Express Q1 revenue falls on lower prescription medication sales - TradingView
PetMeds® Announces First Quarter Financial Results - The Manila Times
PetMed Express (PETS) grants director James LaCamp 55,555 restricted shares - Stock Titan
PetMed Express (PETS) grants director Peter Batushansky 55,555 restricted shares - Stock Titan
PetMed Express (PETS) awards 55,555-share restricted stock grant to director Mennen - Stock Titan
PetMed Express, Inc. expected to post earnings of 12 cents a shareEarnings Preview - TradingView
PetMed Express (PETS) Dips 0.51% to $1.97, Holds Between Support and ResistanceFibonacci Fan - dars.gov.et
Bronstein, Gewirtz & Grossman, LLC Encourages PetMed Express, Inc - The National Law Review
Petmed Express Inc (PETS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PetMed Express, Inc. (PETS) Investigation: Bronstein, Gewirtz & G - The National Law Review
PetMed Express, Inc. (PETS) stock price, news, quote and history - Yahoo Finance UK
Petwealth Unveils Modernized Pet Health Platform at SuperZoo 2026 - AOL.com
PETS Q1'26 Earnings: revenue estimate is 71.00M USD - TradingView
Pet flea treatments face calls for ban over devastating risks to the environment - AOL.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating PetMed Expres - The National Law Review
PetMed Express Inc (NASDAQ: PETS) Share Price, PETS Stock News, PETS Share Price & Updates - Kalkine
PetMeds Beats Pixel Tracking Privacy Suit Over Standing Flaw - Law360
PetMed Express (PETS) Gains 1.28% to $1.98, Edges Toward Resistance at $2.08Oversold Bounce Ideas - dars.gov.et
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
PetMed Express, Inc. to Report First Quarter Fiscal 2026 Financial Results on August 13, 2026 - Quiver Quantitative
PetMeds sets 4:30 p.m. webcast to review first-quarter results - Stock Titan
PetMed Express Inc. (PETS) Q2 2026 Earnings: EPS Misses Estimates Amid Challenging ConditionsGAAP Earnings Report - dars.gov.et
PETS|Petmed Express Inc|Price:1.990|Chg%:+0.010 - TradingKey
Petmed Express Inc (PETS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.17%
0.58%
자본화:
|
볼륨(24시간):